Prognostic Utility of PET in Prostate Cancer.
PET Clin
; 10(2): 255-63, 2015 Apr.
Article
en En
| MEDLINE
| ID: mdl-25829090
ABSTRACT
Many standard nonimaging-based prediction tools exist for prostate cancer. However, these tools may be limited in individual cases and need updating based on the improved understanding of the underlying complex biology of the disease and the emergence of the novel targeted molecular imaging methods. A new platform of automated predictive tools that combines the independent molecular, imaging, and clinical information can contribute significantly to patient care. Such a platform will also be of interest to regulatory agencies and payers as more emphasis is placed on supporting those interventions that have quantifiable and significant beneficial impact on patient outcome.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Asunto principal:
Neoplasias de la Próstata
/
Tomografía Computarizada por Rayos X
/
Tomografía de Emisión de Positrones
Tipo de estudio:
Prognostic_studies
Límite:
Humans
/
Male
Idioma:
En
Revista:
PET Clin
Año:
2015
Tipo del documento:
Article